 |
PDBsum entry 1tmn
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1tmn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.27
- thermolysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Xaa-|-Leu > Xaa-|-Phe.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Ca(2+); Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
23:5724-5729
(1984)
|
|
PubMed id:
|
|
|
|
|
| |
|
Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases.
|
|
A.F.Monzingo,
B.W.Matthews.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The mode of binding of the specific thermolysin inhibitor
N-(1-carboxy-3-phenylpropyl)-L-leucyl-L-tryptophan (KI approximately 5 X 10(-8)
M) [Maycock, A. L., DeSousa, D. M., Payne, L. G., ten Broeke, J., Wu, M. T.,
& Patchett, A. A. (1981) Biochem. Biophys. Res. Commun. 102, 963-969] has
been determined by X-ray crystallography and refined to an R value of 17.1% at
1.9-A resolution. The inhibitor binds to thermolysin with both oxygens of the
N-carboxymethyl group liganded to the zinc to give overall pentacoordination of
the metal. The bidentate ligation of the inhibitor differs from the monodentate
binding seen previously for carboxylate-zinc interactions in thermolysin and is
closer to the bidentate geometry observed for the binding of hydroxamates
[Holmes, M. A., & Matthews, B. W. (1981) Biochemistry 20, 6912-6920]. The
geometry of the inhibitor and its interactions with the protein have a number of
elements in common with the presumed transition state formed during peptide
hydrolysis. The observed zinc ligation supports the previous suggestion that a
pentacoordinate intermediate participates in the mechanism of catalysis.
However, the alpha-amino nitrogen of the inhibitor is close to Glu-143,
suggesting that this residue might accept a proton from an attacking water
molecule (as proposed before) and subsequently donate this proton to the leaving
nitrogen. By analogy with thermolysin, it is proposed that a related mechanism
should be considered for peptide cleavage by carboxypeptidase A.(ABSTRACT
TRUNCATED AT 250 WORDS)
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Qaiser Fatmi,
T.S.Hofer,
and
B.M.Rode
(2010).
The stability of [Zn(NH(3))(4)](2+) in water: A quantum mechanical/molecular mechanical molecular dynamics study.
|
| |
Phys Chem Chem Phys,
12,
9713-9718.
|
 |
|
|
|
|
 |
O.A.Adekoya,
and
I.Sylte
(2009).
The thermolysin family (m4) of enzymes: therapeutic and biotechnological potential.
|
| |
Chem Biol Drug Des,
73,
7.
|
 |
|
|
|
|
 |
R.C.Spitale,
and
J.E.Wedekind
(2009).
Exploring ribozyme conformational changes with X-ray crystallography.
|
| |
Methods,
49,
87.
|
 |
|
|
|
|
 |
X.Wang,
M.Kirberger,
F.Qiu,
G.Chen,
and
J.J.Yang
(2009).
Towards predicting Ca2+-binding sites with different coordination numbers in proteins with atomic resolution.
|
| |
Proteins,
75,
787-798.
|
 |
|
|
|
|
 |
E.Proschak,
M.Rupp,
S.Derksen,
and
G.Schneider
(2008).
Shapelets: possibilities and limitations of shape-based virtual screening.
|
| |
J Comput Chem,
29,
108-114.
|
 |
|
|
|
|
 |
H.Deng,
G.Chen,
W.Yang,
and
J.J.Yang
(2006).
Predicting calcium-binding sites in proteins - a graph theory and geometry approach.
|
| |
Proteins,
64,
34-42.
|
 |
|
|
|
|
 |
A.M.Kennedy,
M.Inada,
S.M.Krane,
P.T.Christie,
B.Harding,
C.López-Otín,
L.M.Sánchez,
A.A.Pannett,
A.Dearlove,
C.Hartley,
M.H.Byrne,
A.A.Reed,
M.A.Nesbit,
M.P.Whyte,
and
R.V.Thakker
(2005).
MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO).
|
| |
J Clin Invest,
115,
2832-2842.
|
 |
|
|
|
|
 |
J.W.Arndt,
W.Yu,
F.Bi,
and
R.C.Stevens
(2005).
Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
|
| |
Biochemistry,
44,
9574-9580.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Swaminathan,
S.Eswaramoorthy,
and
D.Kumaran
(2004).
Structure and enzymatic activity of botulinum neurotoxins.
|
| |
Mov Disord,
19,
S17-S22.
|
 |
|
|
|
|
 |
E.Bianchi,
and
A.Pessi
(2002).
Inhibiting viral proteases: challenges and opportunities.
|
| |
Biopolymers,
66,
101-114.
|
 |
|
|
|
|
 |
J.W.Arndt,
B.Hao,
V.Ramakrishnan,
T.Cheng,
S.I.Chan,
and
M.K.Chan
(2002).
Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus.
|
| |
Structure,
10,
215-224.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Ingallinella,
D.Fattori,
S.Altamura,
C.Steinkühler,
U.Koch,
D.Cicero,
R.Bazzo,
R.Cortese,
E.Bianchi,
and
A.Pessi
(2002).
Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
|
| |
Biochemistry,
41,
5483-5492.
|
 |
|
|
|
|
 |
V.Kairys,
and
M.K.Gilson
(2002).
Enhanced docking with the mining minima optimizer: acceleration and side-chain flexibility.
|
| |
J Comput Chem,
23,
1656-1670.
|
 |
|
|
|
|
 |
A.C.English,
S.H.Done,
L.S.Caves,
C.R.Groom,
and
R.E.Hubbard
(1999).
Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol.
|
| |
Proteins,
37,
628-640.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Fukasawa,
K.M.Fukasawa,
H.Iwamoto,
J.Hirose,
and
M.Harada
(1999).
The HELLGH motif of rat liver dipeptidyl peptidase III is involved in zinc coordination and the catalytic activity of the enzyme.
|
| |
Biochemistry,
38,
8299-8303.
|
 |
|
|
|
|
 |
U.Ryde
(1999).
Carboxylate binding modes in zinc proteins: A theoretical study
|
| |
Biophys J,
77,
2777-2787.
|
 |
|
|
|
|
 |
W.T.Lowther,
A.M.Orville,
D.T.Madden,
S.Lim,
D.H.Rich,
and
B.W.Matthews
(1999).
Escherichia coli methionine aminopeptidase: implications of crystallographic analyses of the native, mutant, and inhibited enzymes for the mechanism of catalysis.
|
| |
Biochemistry,
38,
7678-7688.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.T.Lowther,
Y.Zhang,
P.B.Sampson,
J.F.Honek,
and
B.W.Matthews
(1999).
Insights into the mechanism of Escherichia coli methionine aminopeptidase from the structural analysis of reaction products and phosphorus-based transition-state analogues.
|
| |
Biochemistry,
38,
14810-14819.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Banbula,
J.Potempa,
J.Travis,
C.Fernandez-Catalán,
K.Mann,
R.Huber,
W.Bode,
and
F.Medrano
(1998).
Amino-acid sequence and three-dimensional structure of the Staphylococcus aureus metalloproteinase at 1.72 A resolution.
|
| |
Structure,
6,
1185-1193.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Kojima,
T.Kumazaki,
S.Ishii,
and
K.Miura
(1998).
Primary structure of Streptomyces griseus metalloendopeptidase II.
|
| |
Biosci Biotechnol Biochem,
62,
1392-1398.
|
 |
|
|
|
|
 |
S.T.Huang,
W.E.Choi,
C.Bloom,
M.Leuenberger,
and
M.F.Dunn
(1997).
Carboxylate ions are strong allosteric ligands for the HisB10 sites of the R-state insulin hexamer.
|
| |
Biochemistry,
36,
9878-9888.
|
 |
|
|
|
|
 |
U.Eichhorn,
A.S.Bommarius,
K.Drauz,
and
H.D.Jakubke
(1997).
Synthesis of dipeptides by suspension-to-suspension conversion via thermolysin catalysis: from analytical to preparative scale.
|
| |
J Pept Sci,
3,
245-251.
|
 |
|
|
|
|
 |
A.J.Turner,
and
L.J.Murphy
(1996).
Molecular pharmacology of endothelin converting enzymes.
|
| |
Biochem Pharmacol,
51,
91.
|
 |
|
|
|
|
 |
A.Beaumont,
M.J.O'Donohue,
N.Paredes,
N.Rousselet,
M.Assicot,
C.Bohuon,
M.C.Fournié-Zaluski,
and
B.P.Roques
(1995).
The role of histidine 231 in thermolysin-like enzymes. A site-directed mutagenesis study.
|
| |
J Biol Chem,
270,
16803-16808.
|
 |
|
|
|
|
 |
C.McMartin,
and
R.S.Bohacek
(1995).
Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes.
|
| |
J Comput Aided Mol Des,
9,
237-250.
|
 |
|
|
|
|
 |
C.S.Poornima,
and
P.M.Dean
(1995).
Hydration in drug design. 1. Multiple hydrogen-bonding features of water molecules in mediating protein-ligand interactions.
|
| |
J Comput Aided Mol Des,
9,
500-512.
|
 |
|
|
|
|
 |
G.Klebe,
T.Mietzner,
and
F.Weber
(1994).
Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors.
|
| |
J Comput Aided Mol Des,
8,
751-778.
|
 |
|
|
|
|
 |
G.Klebe,
and
T.Mietzner
(1994).
A fast and efficient method to generate biologically relevant conformations.
|
| |
J Comput Aided Mol Des,
8,
583-606.
|
 |
|
|
|
|
 |
J.C.Spurlino,
A.M.Smallwood,
D.D.Carlton,
T.M.Banks,
K.J.Vavra,
J.S.Johnson,
E.R.Cook,
J.Falvo,
R.C.Wahl,
and
T.A.Pulvino
(1994).
1.56 A structure of mature truncated human fibroblast collagenase.
|
| |
Proteins,
19,
98.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.J.Murphy,
R.Corder,
A.I.Mallet,
and
A.J.Turner
(1994).
Generation by the phosphoramidon-sensitive peptidases, endopeptidase-24.11 and thermolysin, of endothelin-1 and c-terminal fragment from big endothelin-1.
|
| |
Br J Pharmacol,
113,
137-142.
|
 |
|
|
|
|
 |
R.L.DesJarlais,
and
J.S.Dixon
(1994).
A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors.
|
| |
J Comput Aided Mol Des,
8,
231-242.
|
 |
|
|
|
|
 |
M.A.Navia,
and
D.A.Peattie
(1993).
Structure-based drug design: applications in immunopharmacology and immunosuppression.
|
| |
Trends Pharmacol Sci,
14,
189-195.
|
 |
|
|
|
|
 |
M.Hijikata,
H.Mizushima,
T.Akagi,
S.Mori,
N.Kakiuchi,
N.Kato,
T.Tanaka,
K.Kimura,
and
K.Shimotohno
(1993).
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.
|
| |
J Virol,
67,
4665-4675.
|
 |
|
|
|
|
 |
E.Meyer
(1992).
Internal water molecules and H-bonding in biological macromolecules: a review of structural features with functional implications.
|
| |
Protein Sci,
1,
1543-1562.
|
 |
|
|
|
|
 |
R.C.Garratt,
and
H.Jhotí
(1992).
A molecular model for the tumour-associated antigen, p97, suggests a Zn-binding function.
|
| |
FEBS Lett,
305,
55-61.
|
 |
|
|
|
|
 |
W.Stark,
R.A.Pauptit,
K.S.Wilson,
and
J.N.Jansonius
(1992).
The structure of neutral protease from Bacillus cereus at 0.2-nm resolution.
|
| |
Eur J Biochem,
207,
781-791.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.R.Attwood
(1989).
Chemical design of cilazapril.
|
| |
Br J Clin Pharmacol,
27,
133S-137S.
|
 |
|
|
|
|
 |
D.E.Tronrud,
A.F.Monzingo,
and
B.W.Matthews
(1986).
Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin.
|
| |
Eur J Biochem,
157,
261-268.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.W.Christianson,
and
W.N.Lipscomb
(1986).
X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature.
|
| |
Proc Natl Acad Sci U S A,
83,
7568-7572.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.G.Hangauer,
P.Gund,
J.D.Andose,
B.L.Bush,
E.M.Fluder,
E.F.McIntyre,
and
G.M.Smith
(1985).
Modeling the mechanism of peptide cleavage by thermolysin.
|
| |
Ann N Y Acad Sci,
439,
124-139.
|
 |
|
|
|
|
 |
D.W.Christianson,
and
W.N.Lipscomb
(1985).
Binding of a possible transition state analogue to the active site of carboxypeptidase A.
|
| |
Proc Natl Acad Sci U S A,
82,
6840-6844.
|
 |
|
|
|
|
 |
M.J.Wyvratt,
and
A.A.Patchett
(1985).
Recent developments in the design of angiotensin-converting enzyme inhibitors.
|
| |
Med Res Rev,
5,
483-531.
|
 |
|
|
|
|
 |
S.J.Gardell,
C.S.Craik,
D.Hilvert,
M.S.Urdea,
and
W.J.Rutter
(1985).
Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis.
|
| |
Nature,
317,
551-555.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |